Home Pi-Cardia Ltd

Pi-Cardia Ltd

Non-Implant Based Leaflex™ Catheter First-in-Human Study Results

The First-In-Human study aimed to demonstrate safety, feasibility and acute performance of the Leaflex™ catheter as a standalone treatment, and included sixteen (16) transfemoral cases where Leaflex™ was used prior to TAVR.